Epigenetics Market worth 890.0 Million USD by 2020

1. MarketsandMarkets Presents Epigenetics Market by Product Global Forecast to 2020 http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html

2. The report “Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the epigeneticsmarket along with the estimates and forecasts of the revenue and market share analysis. Browse: 84 market data tables 82figures 158 pages And in-depth TOC on “Epigenetics Market” Get The PDF Brochure For This Report: http://www.marketsandmarkets.com/pdfdownload.asp?id=896 The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020. http://www.marketsandmarkets.com/Market-Reports/urinalysis-systems-market-153479294.html

3. This report segments the global epigenetics market by product and research areas. The global market product segments include enzymes, instruments & consumables, kits and reagents. Enzymes are further subsegmented into DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes. Instruments & consumables are further subsegmented into mass spectrometers, next-generation sequencers, qPCRs, sonicators and other epigenetics instruments & consumables. The research area segments of this market are developmental biology, drug discovery, oncology and other research areas. Other research areas include genome-wide regulatory mechanisms and research related to several metabolic and genetic diseases. Request a sample of the report: http://www.marketsandmarkets.com/requestsample.asp?id=896 Major players in the global epigenetics market are Abcam plc. (U.K), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherland), Merck & Co. (U.S.), New England Biolabs, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Active Motif (U.S.), Diagenode, Inc. (Belgium) and Zymo Research Corporation (U.S.). http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html

4. The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). North America is further subsegmented into the U.S. and Canada. In 2015, the North America is expected to command the largest share of the global epigenetics market. Asia is expected to register the highest growth due to high prevalence of cancer, increasing research activities by various research institutes and increasing R & D funding by biotechnology and pharmaceutical companies in this region. • Global Epigenetics Market, by Research Areas • Developmental Biology • Drug Discovery • Oncology • Other Epigenetics Research Areas • Global Epigenetics Market, by Geography • North America • U.S. • Canada • Europe • Asia • Rest of the World http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html

5. Increasing research activities by academic and research institutes and high prevalence of cancer will majorly drive the growth of the market. Other growth factors include the increasing application for non-oncology diseases; and growing partnership between academic, biotechnology and pharmaceutical companies. The new emerging markets such as Brazil, Russia, India and China will provide opportunities for market growth. Key Players : Major players in the global epigenetics market are Abcam plc. (U.K), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherland), Merck & Co. (U.S.), New England Biolabs, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Active Motif (U.S.), Diagenode, Inc. (Belgium) and Zymo Research Corporation (U.S.). Speak to Analyst : http://www.marketsandmarkets.com/speaktoanalyst.asp?id=896 http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html

6. About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.  http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html

7. Contact Us Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.comMarketsandMarkets Bloghttp://www.marketsandmarkets.comhttp://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets